Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma
Authors
Keywords
-
Journal
Immunotherapy
Volume 13, Issue 5, Pages 397-407
Publisher
Future Medicine Ltd
Online
2021-02-09
DOI
10.2217/imt-2020-0263
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Convalescent plasma as a potential therapy for COVID-19
- (2020) Long Chen et al. LANCET INFECTIOUS DISEASES
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
- (2020) Yun Xie et al. JOURNAL OF INFECTION
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
- (2020) Janice Hopkins Tanne BMJ-British Medical Journal
- Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
- (2020) Ruklanthi de Alwis et al. EBioMedicine
- High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
- (2020) Wei Cao et al. Open Forum Infectious Diseases
- Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
- (2020) Alan A. Nguyen et al. CLINICAL IMMUNOLOGY
- Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
- (2020) Lisa Weidner et al. JOURNAL OF CLINICAL VIROLOGY
- Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
- (2020) Ren Yang et al. EBioMedicine
- Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials
- (2020) Alexandra Abrams-Downey et al. European Urology Focus
- Antibody therapies for the prevention and treatment of viral infections
- (2017) Georgina Salazar et al. npj Vaccines
- Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?
- (2015) Hasssan Abolhassani et al. Expert Review of Clinical Immunology
- Minipool Caprylic Acid Fractionation of Plasma Using Disposable Equipment: A Practical Method to Enhance Immunoglobulin Supply in Developing Countries
- (2015) Magdy El-Ekiaby et al. PLoS Neglected Tropical Diseases
- Human plasma-derived immunoglobulin G fractionated by an aqueous two-phase system, caprylic acid precipitation, and membrane chromatography has a high purity level and is free of detectablein vitrothrombogenic activity
- (2014) M. Vargas et al. VOX SANGUINIS
- Applicability of bacterial endotoxins test to various blood products by the use of endotoxin-specific lysates
- (2010) Masaki Ochiai et al. BIOLOGICALS
- Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance
- (2009) M. Radosevich et al. VOX SANGUINIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started